Likewise, Zhang et al. screened for possible MUC16 promoters and attempted specific expression utilizing follicle-stimulating hormone peptide-conjugated gro-α shRNA nanoparticle delivery to ovarian cancer cells [17]. The gene discussed is MUC16; the disease is ovarian cancer.